China still has ‘catching up to do’ to become biotech powerhouse, JPMorgan says

Summary
A lag in foundational research and looming geopolitical risks will weigh on China’s bid to build a world-class biotechnology innovation ecosystem, even as the sector’s overseas momentum remains strong, according to JPMorgan. “In China, there is still some catching up to do in basic research, particularly in biological and pharmaceutical research,” said Yang Huang, head of China healthcare research at JPMorgan, during an interview on Wednesday. To meet the “ambitious goal” set in the country’s...
Description from South China Morning Post.
Who is covering this
-
China still has ‘catching up to do’ to become biotech powerhouse, JPMorgan says
A lag in foundational research and looming geopolitical risks will weigh on China’s bid to build a world-class biotechnology innovation ecosystem, even as the sector’s overseas momentum remains strong, according to JPMorgan. “In China, there is still some catching up to do in...
Comments
Comments need JavaScript.